Willingness to pay for accommodating job attributes when returning to work after cancer treatment: A discrete choice experiment with Danish breast cancer survivors

Abstract Purpose To assess the status of returning to work (RTW) following breast cancer treatment and to explore its associated factors among female patients. Methods Four-hundred-forty-two eligible patients admitted in a tertiary hospital since 2012 were followed up in 2018. Information about working status after treatment, date of RTW or reason for not RTW was obtained during a 30-min interview. Patients’ sociodemographic, disease, and treatment characteristics were retrieved from the hospital record. Overall prevalence rate and probability of RTW during the follow-up were estimated using Kaplan–Meier method. Factors associated with RTW were identified using regression analyses. Results Three-hundred-ninety-six patients (89.6%) completed the follow-up. The median follow-up was 31 months. Among them, 141 patents (35.6%) RTW of whom 68.1% (n = 96) were back within 12 months after cancer treatment. The reported reasons for not RTW included: prolonged fatigue, low self-esteem, lack of support from family and working unit, or voluntarily quitting. Patients aged under 50 years, being single, having higher level of education, not having extensive axillary node procedure, or without any comorbidities were more likely to RTW. Conclusion The rate of RTW after cancer treatment in this cohort was lower than those reported in others. Both personal and treatment factors were associated with RTW.

Download Full-text

Childhood Trauma Predicts Cancer Treatment–Related Pain in Breast Cancer Survivors

Cancer Nursing ◽

10.1097/ncc.0000000000000687 ◽

2019 ◽

Vol 43 (4) ◽

pp. E207-E216

Author(s):

Grace A. Kanzawa-Lee ◽

Robert Knoerl ◽

David A. Williams ◽

Daniel J. Clauw ◽

Celia M. Bridges ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Survivors ◽

Cancer Treatment ◽

Childhood Trauma ◽

Breast Cancer Survivors

Download Full-text

Combining Individual-Level Discrete Choice Experiment Estimates and Costs to Inform Health Care Management Decisions about Customized Care: The Case of Follow-Up Strategies after Breast Cancer Treatment

Value in Health ◽

10.1016/j.jval.2012.04.007 ◽

2012 ◽

Vol 15 (5) ◽

pp. 680-689 ◽

Cited By ~ 15

Author(s):

Tim M. Benning ◽

Merel L. Kimman ◽

Carmen D. Dirksen ◽

Liesbeth J. Boersma ◽

Benedict G.C. Dellaert

Keyword(s):

Breast Cancer ◽

Health Care ◽

Cancer Treatment ◽

Discrete Choice Experiment ◽

Discrete Choice ◽

Choice Experiment ◽

Care Management ◽

Breast Cancer Treatment ◽

Individual Level

Download Full-text

Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study

Breast Cancer Research and Treatment ◽

10.1007/s10549-009-0321-5 ◽

2009 ◽

Vol 118 (2) ◽

pp. 395-405 ◽

Cited By ~ 121

Author(s):

Neela Guha ◽

Marilyn L. Kwan ◽

Charles P. Quesenberry ◽

Erin K. Weltzien ◽

Adrienne L. Castillo ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Survivors ◽

Breast Cancer Survivors ◽

Cancer Recurrence ◽

Cancer Epidemiology ◽

Soy Isoflavones ◽

Epidemiology Study ◽

After Cancer ◽

Risk Of Cancer

Download Full-text

Divorce after breast cancer diagnosis and its impact on quality of life

Palliative & Supportive Care ◽

10.1017/s1478951521001711 ◽

2021 ◽

pp. 1-6

Author(s):

Danbee Kang ◽

Nayeon Kim ◽

Gayeon Han ◽

Sooyeon Kim ◽

Hoyoung Kim ◽

...

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Cancer Survivors ◽

Cancer Diagnosis ◽

Breast Cancer Survivors ◽

Breast Cancer Diagnosis ◽

Factors Associated ◽

After Cancer ◽

The Impact

Abstract Objective This study aims to identify factors associated with divorce following breast cancer diagnosis and measures the impact of divorce on the quality of life (QoL) of patients. Methods We used cross-sectional survey data collected at breast cancer outpatient clinics in South Korea from November 2018 to April 2019. Adult breast cancer survivors who completed active treatment without any cancer recurrence at the time of the survey (N = 4,366) were included. The participants were classified into two groups: “maintaining marriage” and “being divorced,” between at the survey and at the cancer diagnosis. We performed logistic regression and linear regression to identify the factors associated with divorce after cancer diagnosis and to compare the QoL of divorced and nondivorced survivors. Results Approximately 11.1/1,000 of married breast cancer survivors experienced divorce after cancer diagnosis. Younger age, lower education, and being employed at diagnosis were associated with divorce. Being divorced survivors had significantly lower QoL (Coefficient [Coef] = −7.50; 95% CI = −13.63, −1.36), social functioning (Coef = −9.47; 95% CI = −16.36, −2.57), and body image (Coef = −8.34; 95% CI = −6.29, −0.39) than survivors who remained married. They also experienced more symptoms including pain, insomnia, financial difficulties, and distress due to hair loss. Conclusion Identifying risk factors of divorce will ultimately help ascertain the resources necessary for early intervention.

Download Full-text

Inflammatory Cytokines and Comorbidity Development in Breast Cancer Survivors Versus Noncancer Controls: Evidence for Accelerated Aging?

Journal of Clinical Oncology ◽

10.1200/jco.2016.67.1883 ◽

2017 ◽

Vol 35 (2) ◽

pp. 149-156 ◽

Cited By ~ 26

Author(s):

Catherine M. Alfano ◽

Juan Peng ◽

Rebecca R. Andridge ◽

Monica E. Lindgren ◽

Stephen P. Povoski ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Survivors ◽

Cancer Treatment ◽

Breast Cancer Survivors ◽

Accelerated Aging ◽

Premature Mortality ◽

Control Group ◽

Factor Α ◽

Necrosis Factor ◽

Over Time

Purpose The sequelae of cancer treatment may increase systemic inflammation and create a phenotype at increased risk of functional decline and comorbidities, leading to premature mortality. Little is known about how this trajectory compares with natural aging among peers of the same age without cancer. This longitudinal study investigated proinflammatory cytokines and comorbidity development over time among breast cancer survivors and a noncancer control group. Methods Women (N = 315; 209 with breast cancer and 106 in the control group) were recruited at the time of their work-up for breast cancer; they completed the baseline questionnaire, interview, and blood draw (lipopolysaccharide-stimulated production of interleukin [IL] -6, tumor necrosis factor-α, and IL-1β). Measures were repeated 6 and 18 months after primary cancer treatment (cancer survivors) or within a comparable time frame (control group). Results There were no baseline differences in comorbidities or cytokines between survivors and the control group. Over time, breast cancer survivors had significantly higher tumor necrosis factor-α and IL-6 compared with the control group. Survivors treated with surgery, radiation, and chemotherapy accumulated a significantly greater burden of comorbid conditions and suffered greater pain associated with inflammation over time after cancer treatment than did the control group. Conclusion Survivors who had multimodal treatment had higher cytokines and comorbidities, suggestive of accelerated aging. Comorbidities were related to inflammation in this sample, which could increase the likelihood of premature mortality. Given that many comorbidities take years to develop, future research with extended follow-up beyond 18 months is necessary to examine the evidence of accelerated aging in cancer survivors and to determine the responsible mechanisms.

Download Full-text